Yale New Haven Health Innovation Award winners
The YNHHS Center for Health Care Innovation (CHI) has announced the winners of the Yale New Haven Health (YNHHS) Innovation Awards, in celebration of early-stage innovations. Established...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
The YNHHS Center for Health Care Innovation (CHI) has announced the winners of the Yale New Haven Health (YNHHS) Innovation Awards, in celebration of early-stage innovations. Established...
View this email in your browser Weekly Roundup – September 8, 2022 As Women In Bio continues to celebrate 20 years of community, allyship, and advocacy for...
Marcum LLP, an accounting firm with offices in New Haven, has completed its merger with New York-based Friedman LLP. The new firm, called Marcum, now operates in...
Boehringer Ingelheim reports that the FDA has approved SPEVIGO, the first approved treatment option for generalized pustular psoriasis (GPP) flares in adults. SPEVIGO is a novel,...
CaroGen reports that Bijan Almassian, PhD, President & CEO, and Timur Yarovin-sky, MD, PhD, Vice President of Discovery, have been invited to speak at The World...
The National Human Genome Research Institute has awarded genomics expert Brent Graveley and his team $5.6-million to continue to work on an enormous encyclopedia of...
Medtronic has entered into a strategic partnership with BioIntelliSense for the exclusive U.S. hospital and 30-day post-acute hospital to home distribution rights of the BioButton® multi-parameter...
View this email in your browser Weekly Roundup – September 1, 2022 UConn’s Office of the Vice President for Research, Technology Commercialization Services (TCS) works with innovators,...
Yale New Haven Hospital plans to break ground on its new $838 million neurosciences center at its Saint Raphael campus, two years after delaying the project...
With the acquisition of Phase 2 ready assets from Cresence AS, Bioasis becomes a clinical stage company with a multi-asset pipeline focused on rare and orphan drugs....